Average Co-Inventor Count = 5.04
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (11 from 2,078 patents)
2. Boehringer Ingelheim Pharmaceuticals, Inc. (3 from 276 patents)
3. Other (1 from 832,880 patents)
4. Ortho-mcneil Pharmaceutical Corp. (1 from 363 patents)
5. 3-dimensional Pharmaceuticals, Inc. (1 from 77 patents)
17 patents:
1. 10251864 - Indole derivatives useful as glucagon receptor antagonists
2. 9012412 - Dual SGLT1/SGLT2 inhibitors
3. 8796256 - Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-α modulators
4. 8748624 - Picolinamido-propanoic acid derivatives useful as glucagon receptor antagonists
5. 8604190 - Hetero isonipecotic modulators of vanilloid VR1 receptor
6. 8445690 - Aminothiazolones as estrogen related receptor-alpha modulators
7. 8426604 - Aminothiazolones as estrogen related receptor-alpha modulators
8. 8399681 - Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators
9. 8263781 - Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators
10. 8022209 - [object Object]
11. 7829566 - 4-amino-quinazolines
12. 7705151 - 1,6 Naphthridines useful as inhibitors of SYK kinase
13. 7678911 - 1,6 naphthyridines useful as inhibitors of SYK kinase
14. 7622579 - Hetero isonipecotic modulators of vanilloid VR1 receptor
15. 7547702 - 4-amino-quinazolines